Gain-of-function mutations of PCSK9 are associated with familial hypercholesterolemia and premature cardiovascular disease [3], while PCSK9 deficiency leads to low LDL cholesterol concentrations and protection against cardiovascular disease [4]. The gene discussed is PCSK9; the disease is familial hypercholesterolemia.